Abstract
Background and objective
Circumscribed choroidal haemangioma (CCH) has several characteristic clinical and angiographic features. We aimed to compare indocyanine green angiography (ICG) findings of CCH captured on a traditional digital camera system (DCS) to newer scanning laser ophthalmoscopy (SLO) platforms.
Study design/materials and methods
A total of 35 patients over a 10-year period diagnosed with CCH using ICG were included (18 imaged with DCS and 17 with SLO).
Results
On early ICG frames, intrinsic vessels were apparent in two-thirds (12/18; 67%) of the DCS group compared with all of eyes in the SLO group (p = 0.020). In addition, at maximal hyperfluorescence, most eyes imaged with DCS had a feathery appearance (16/18; 89%) compared with those in the SLO group which all (17/17; 100%) displayed a granular appearance (p < 0.001). The presence of hot spots at maximal hyperfluorescence was also more common in the SLO group (12/17; 71%) versus the DCS group (0/18; 0%) (p < 0.001). Finally, intrinsic vessels and vascular loops could be identified throughout the entire duration of the ICG in 100% of the SLO cases (17/17) versus only 11% (2/18) of DCS cases (p < 0.001).
Conclusions
The visualization of intrinsic vessels, vascular loops, and “hot spots” in CCH is significantly enhanced with SLO compared with DCS. Many characteristic mid-late angiographic findings of CCH are more optimally visualized on SLO which may negate the need for late frames (>30 min) without compromising diagnostic accuracy.
Subject terms: Uveal diseases, Eye abnormalities
Introduction
Circumscribed choroidal haemangiomas (CCH) are benign, vascular tumors that tend to be solitary and unilateral in nature. They have a characteristic red-orange appearance and can have overlying retinal pigment epithelium (RPE) hyperplasia (33%) or fibrous metaplasia (20%) [1]. Most commonly, CCH involve the superotemporal quadrant of the macula [2] and tend to present in the 5th decade of life, often with decreased visual acuity and a serous macular detachment [1]. Circumscribed choroidal haemangioma has historically been categorized as a congenital lesion without associated ocular or systemic anomalies [3]. However, recent reports of increased subfoveal choroidal thickness [4] and irregular choroidal vascular architecture have suggested that predisposing ocular factors may impart a propensity for the growth of this hamartomatous lesion [5].
Several findings on ancillary studies can support the diagnosis of CCH. Clinically, CCH often transilluminates during slit lamp biomicroscopy when a small, bright beam is centered over the lesion. This vascular tumor shows high internal reflectivity on ultrasound A-scan and appears as a solid, dome shaped mass on ultrasound B-scan [1, 6]. Enhanced depth imaging optical coherence tomography (EDI-OCT) shows expansion of vessels in Haller’s and Sattler’s layers [7], but unlike choroidal nevi [8], melanoma [9], and metastasis [10], the choriocapillaris is not compressed. On fluorescein angiography (FA), progressive hyperfluorescence is typically seen with diffuse, late staining of the tumor [1, 2]; however, given that these features may be absent in up to two-thirds of cases, many consider indocyanine green angiography (ICG) to supersede FA.
Given the anatomical location of CCH, ICG has been employed with a characteristic pattern of early uptake by the tumor, followed by an increase in fluorescent intensity, with late washout due to its highly vascular nature. Previously published landmark studies describing ICG characteristics of CCH used digital fundus photography based imaging systems (Topcon TRC 50 IA fundus camera) [11]. The purpose of this study was to compare the well documented color fundus photographic and ICG characteristics of CCH captured on digital camera systems (DCS) to the features appreciated on newer scanning laser ophthalmoscopy (SLO) platforms (Optos California and Heidelberg Spectralis).
Materials and methods
Following registration with and approval by the clinical audit department (audit number 530), consecutive eyes diagnosed with CCH over a 10-year period (January 1, 2007 to December 31, 2017) in the Ocular Oncology Service of Moorfields Eye Hospital were identified. In 2016 we began transitioning from ICG on DCS to SLO. A total of 35 eyes that had ICG studies taken on standard imaging settings were included; 18 of these had digital ICG photographs taken using DCS (Topcon fundus camera, Topcon Corporation, Tokyo, Japan) and 17 had images captured using SLO platforms (Optos California [Optos plc, Dunfermline, Scotland] and Heidelberg Spectralis [Heidelberg Engineering GmbH, Heidelberg, Germany]). All of those imaged with SLO had ICG angiography captured on Heidelberg Spectralis and fundus photographs taken with Optos.
The DCS used a halogen lamp, a polychromatic light source, to illuminate the retina. For ICG, an excitation filter of 640–780 nm and a barrier filter of 820–900 were used, respectively.
In the SLO group a monochromatic laser light source is used to illuminate the retina, rather than a halogen lamp as is used in DCS. The Optos California images were obtained using a combination of four laser wavelengths: blue (488 nm), green (532 nm), red (635 nm), and infrared (IR) (802 nm). The Optomap® pseudocolor image was generated using the green and red lasers, whereas the Optos autofluorescence image was generated using the green laser. The Heidelberg Spectralis OCT used a wavelength of 870 nm and the Spectralis ICG excitation was by a diode laser of 790 nm and a barrier filter of 830 nm [12].
Patient files were reviewed for demographic data, including gender and age at time of diagnosis. All images were reviewed, and variables recorded included color of the tumor on DCS versus SLO as well as ICG features of the tumor, such as visualization of intrinsic vessels and presence or absence of “hot spots.” The pattern at maximal hyperfluorescence was categorized either “feathery” or “granular.” Lesions categorized as “feathery” had blurred tumor margins and indistinct intralesional features. Those defined as “granular” had distinct margins and pixelated intratumoral characteristics. Diffuse versus patchy were used as additional descriptive terms, with the former indicating a homogenous appearance throughout the entire lesion. As there was variability amongst cases with respect to duration of imaging, the timing of the latest frame was also recorded. This image was assessed for a relative decrease in fluorescence of the lesion, presence of “hot spots,” “washout” of the lesion and presence of a hyperfluorescent rim. “Washout” was further classified as complete versus partial depending on whether the entire lesion or only a portion of it became hypofluorescent compared with the rest of the choroid. We defined “early” as <1 min, “mid” as 1–3 min, and “late” as >7 min.
Data are presented as mean ± standard deviation (SD) when normally distributed or as median and (interquartile range) if not. Normality was assessed using the Shapiro–Wilks test. Differences in continuous variables were compared using a student’s t test or the Mann–Whitney U test for normally and not normally distributed data, respectively. Differences in proportions between the groups were analyzed using Fisher’s exact test with the Freeman–Halton extension. A p value of <0.05 was considered statistically significant. All data were analyzed using a commercially available software package (SPSS® 25; IBM Corporation, Armonk, NY, USA).
Results
A total of 35 eyes with CCH evaluated with ICG angiography were included in this study. The mean age at diagnosis for the entire cohort was 53.8 ± 13.2 years. The majority of patients were male (74%) and right eyes (63%) were affected more commonly than left. Approximately half of the cases had imaging captured on DCS (18 eyes, 51%) versus SLO (17 eyes, 49%). Overall, the mean (±SD) CCH thickness and largest basal diameter was 2.1 ± 1.8 and 6.8 ± 1.9 mm. Most lesions were associated with subretinal fluid (24/27; 89%) and located within the macula (25/35; 71%). There was no difference CCH characteristics between the DCS and SLO groups (Table 1).
Table 1.
Comparison of demographic and imaging characteristics of patients with circumscribed choroidal haemangioma undergoing ICG imaging with either digital camera system (Topcon) or scanning laser ophthalmoscope (Heidelberg Spectralis).
| DCS | SLO | p value | |
|---|---|---|---|
| n = 18 | n = 17 | ||
| Age (mean ± SD) | 49.9 ± 12.8 | 57.9 ± 12.7 | 0.071 |
| Gender (%) | 1.000 | ||
| Male | 13 (72) | 13 (76) | |
| Female | 5 (28) | 4 (24) | |
| Haemangioma characteristics | |||
| Size (mm) | |||
| Thickness (mean ± SD) | 2.3 ± 1.0 | 2.1 ± 0.7 | 0.872 |
| Largest basal dimension (mean ± SD) | 6.9 ± 2.3 | 6.8 ± 1.4 | 0.938 |
| Presence of SRFa (%) | 10/10 (100)a | 14/17 (82) | 0.274 |
| Located within the macula | 11/18 (61) | 14/17 (82) | 0.462 |
| Intrinsic vessels and vascular loops visible on early frames (%) | 12/18 (67) | 16/16 (100)b | 0.020 |
| Pattern at maximal hyperfluorescence (%) | <0.001 | ||
| Granular | 2/18 (11) | 17/17 (100) | |
| Feathery | 16/18 (89) | 0/17 (0) | |
| Patchy | 4/16 (22) | ||
| Diffuse | 12/16 (67) | ||
| Presence of hot spots at maximal hyperfluorescence (%) | 0 (0) | 12 (71) | <0.001 |
| Latest frame recorded (s) (mean ± SD) | 677 ± 159 | 918 ± 720 | 0.590 |
| Decrease in fluorescence at latest frame (%) | 18/18 (100) | 17/17 (100) | 1.000 |
| Washout at latest frame (no. cases/%) | 0.076 | ||
| Complete | 1 (6) | 3 (18) | |
| Partial | 6 (33) | 10 (59) | |
| No | 11 (61) | 4 (24) | |
| Later hyperfluorescent rim (%) | 0.043 | ||
| Complete | 1/18 (6) | 5/17 (29) | |
| Partial | 3/18 (17) | 6/17 (35) | |
| No | 14/18 (78) | 6/17 (35) | |
| Hot spots on late frames | 0.003 | ||
| Prominent | 5/18 (28) | 14/17 (82) | |
| Subtle | 7/18 (39) | 3/17 (18) | |
| No | 5/18 (28) | 0/17 (0) | |
| Visualization of intrinsic vessels throughout entire ICG (%) | 2/18 (11) | 17/17 (100) | <0.001 |
DCS digital camera system, SLO scanning laser ophthalmoscopy, SRF subretinal fluid.
The bold values throughout the table highlight the statistically significant results.
aThe presence or absence of subretinal fluid was not clearly documented in eight cases.
bEarly frames were not available for one patient in the SLO group.
The appearance of CCH on the color image varied significantly between the groups. Images captured with DCS more accurately represented the true red-orange fundoscopic appearance of CCH (Figs. 1a and 2a) compared with SLO, where the lesion appeared to have a green-gray hue (Figs. 3a and 4a). As SLO produces an artificial color image created by the reflectance patterns of two laser wavelengths, the red and green images can be separated using the blend function. In cases of CCH, the red separation image (Figs. 3b and 4b) further highlights the choroidal location and true extent of this lesion, compared with the green separation image (Figs. 3c and 4c).
Fig. 1. Juxtapapillary circumscribed choroidal hemangioma imaged with DCS.
a Digital color photograph depicting a red-orange CCH superior to the optic nerve in the right eye. b Fine, lacy intrinsic vessels are appreciated on the early DCS ICG frames; c however, by the time maximal hyperfluorescence is reached the intrinsic vascular architecture of the lesion can no longer be appreciated and the CCH takes on a diffuse, feathery pattern of hyperfluorescence. d At the latest frame, there is partial washout of the lesion (white stars) and an early hyperfluorescent rim (black stars).
Fig. 2. Circumscribed choroidal hemangioma imaged with DCS.
a Digital color photograph depicting a small, red-orange CCH superotemporal to the optic nerve in the right eye. b A few feathery intrinsic vessels are noted on early ICG frames (white arrows). c The lesion fills very rapidly and appears diffusely hyperfluorescent with feathery borders obscuring the previously evident intralesional vascular architecture. d At the latest frame, there is a relative decrease in hyperfluorescence; however, no washout or hyperfluorescent rim is noted.
Fig. 3. Macular CCH imaged with SLO.
a Scanning laser ophthalmoscope (Optomap®) pseudocolor image of a superotemporal CCH. b Red separation and c green separation images highlighting the choroidal location of the lesion. d Early SLO ICG (Spectralis) frames demonstrate prominent, lacy intrinsic vessels. e At maximum hyperfluorescence, a granular pattern of hyperfluorescence with several “hot spots” and visualization of vascular loops (black arrows). f On the latest frame, the CCH maintains a granular appearance with a number of hot spots remaining with partial washout (white star) and hyperfluorescent rim (black star).
Fig. 4. Sub-foveal CCH imaged with SLO.
a Scanning laser ophthalmoscope (Optomap®) pseudocolor image of CCH with b red and c green separation images highlighting choroidal location of the lesion. d Prominent, lacy intrinsic vessels are well visualized on early Spectralis ICG frames and e at maximum hyperfluorescence, a granular pattern of hyperfluorescence with several “hot spots” and visualization of vascular loops (black arrow) is again apparent. f On the latest frame, there is partial washout (white stars). The vascular loops remain visualized into the latest frame and a partial hyperfluorescent rim (black star) can also be appreciated.
During ICG angiography, several notable differences were seen between the two groups. On early frames, intrinsic vessels were apparent in two-thirds (12/18; 67%) of the DCS group compared with all of eyes in the SLO group (p = 0.020). At maximal hyperfluorescence, most eyes imaged with DCS had a feathery appearance (16/18; 89%) (Figs. 1c and 2c) compared with those in the SLO group which all displayed a granular appearance (Figs. 3e and 4e) (p < 0.001). Of the 16 eyes demonstrating a feathery appearance on DCS, 22% (4/16) showed patchy variation throughout the lesion and 67% (12/16) had a diffuse homogenous appearance. The presence of hot spots at maximal hyperfluorescence reached a statistically significant difference between the modalities, as hot spots were apparent in the majority of SLO (12/17; 71%) versus none of the DCS cases (0/18; 0%) (p < 0.001).
There was no difference in the latest frame recorded between the two imaging modalities (p = 0.590) and irrespective of the imaging platform employed, all eyes showed a relative decrease in fluorescence in the late frames. More eyes imaged on SLO displayed a complete (3/17; 18%) or partial (10/17;59%) washout compared with DCS (1/18; 6% and 6/18; 33%, respectively), though this effect did not reach statistical significance (p = 0.076). Significantly more eyes in the SLO cohort displayed a late hyperfluorescent rim (11/17; 65% versus 4/18; 22%; p = 0.043) and hot spots were more commonly a prominent feature of the late frames captured on SLO (14/17; 82%) compared with DCS (5/18; 28%) (p = 0.003).
The most striking difference between the imaging modalities was in the ability to identify intrinsic vessels and vascular loops throughout the entire duration of the ICG (2/18; 11% of DCS cases versus 17/17; 100% of SLO cases) (p < 0.001) (Table 1).
Discussion
Differentiation of nonpigmented choroidal lesions based solely upon their clinical appearance can be challenging, and as such, multimodal imaging plays a crucial role in narrowing the diagnostic considerations. Although several features of CCH have been well described, in two large series only 1/3rd of patients were referred with the correct diagnosis [1, 2]. CCH tend to have a solid, dome shape appearance with relatively high internal reflectivity on ultrasonography [1, 6] and a smooth, gently sloping contour without choriocapillaris compression on EDI-OCT [7]. Their typical red-orange color leads to a wide differential diagnosis, which can be refined by the use of multimodal imaging.
Yannuzzi et al. first described ICG angiography with DCS as a tool to enhance choroidal imaging and in particular, to assist in the detection of occult choroidal neovascular membranes in patients with age-related macular degeneration [13]. In contemporary clinical practice, ICG is used to aide in the diagnosis, classification, and treatment of a select group of chorioretinal disorders [14], including polypoidal choroidal vasculopathy [15] and retinal angiomatous proliferation [16], central serous chorioretinopathy [17, 18], choroidal inflammatory conditions [19], and CCH [11, 20, 21].
On ICG captured with DCS, CCH display early hyperfluorescence, late “washout,” visualization of intrinsic vessels, a late hyperfluorescent rim and late “hot spots” [11]. However, as patterns on ICG classically reported using DCS differ from that observed with newer SLO platforms, there is a need to further describe the latter. Compared with previous studies, our series had a relatively low rate of “washout” in both groups. This is likely due to the fact that only three patients had “late” frames acquired >30 min. However, the characteristic “early” and “mid” frame findings reported in this series suggest that in some cases, acquisition of images > 30 min are not required to confirm the diagnosis.
In a large series, 29% of patients with CCH were referred with the diagnosis of choroidal melanoma [1] and overall, CCH comprises roughly 5% of all cases of pseudomelanomas [22]. Several ancillary studies may aide in differentiating the former from the latter, including ultrasonography with standardized A-scan (high versus low internal reflectivity) and sparing versus compression of the choriocapillaris on EDI-OCT [9]. Moreover, on ICG choroidal melanomas reach maximum hyperfluorescence much later than CCH (18.2 versus 1.2 min; respectively) and the majority of choroidal melanomas [23] and choroidal nevi remain hypofluorescent compared with the surrounding choroid throughout the entire angiographic study [24].
Appearance of CCH on color photos and red versus green separation images
Circumscribed choroidal haemangioma clinically appears as a red-orange choroidal mass, most commonly in the superotemporal quadrant near the macula [2]. The Optomap® image is artificially constructed from the reflectance patterns of two laser wavelengths, which have variable penetrance of the retinal structure. The green laser is unable to penetrate the RPE, whereas the red is readily able to. Consequently, these images can be useful in giving information as to the depth of a lesion. Gray-green lesions on pseudocolor SLO imaging tend to be choroidal [25]. However, the darker pseudocolor of CCH may further simulate the appearance of pigmented lesions, such as choroidal nevi or melanoma. As such, it is critical for clinicians to be aware of the misleading color photographic representation of CCH on SLO to avoid this diagnostic pitfall. Although the pseudocolor image of SLO less accurately reflects the true fundoscopic appearance, its fundamental constructs can be exploited to produce a red separation image that more clearly highlights the true extent of the CCH, which may be underestimated on DCS.
Presence of intrinsic vessels
Balasubramaniam et al. aimed to characterize the features of choroidal tumors on IR imaging, and found that vascular loops on IR imaging showed a high diagnostic sensitivity for CCH [20]. Similarly, we found that all patients undergoing ICG imaging with SLO platforms had vascular loops and intrinsic vessels visualized throughout the entire angiogram. While DCS captured intrinsic vessels in two-thirds of patients in early frames, the visualization of this feature was only apparent in 11% (2/18) of patients throughout the entire angiogram.
Pattern in mid and late frames
At maximal hyperfluorescence, all eyes imaged in the SLO group had a granular appearance, again with visualization of intrinsic vessels and vascular loops. This appearance was markedly different from the feathery, diffuse and rather homogenous hyperfluorescence seen in the DCS group. On late frames, hot spots were present in 100% in the SLO group versus 67% of the DCS group. Moreover, the “hot spots” were subjectively more intense in the SLO group compared with the DCS group. Arevalo et al. hypothesized that the “hot spots” visualized on late frames represent residual dye remaining in the intrinsic vessels of CCH [11]. Taken together, the findings of this series suggest that intrinsic vessels are better imaged with SLO, which may explain why late “hot spots” were also a consistently prominent finding.
The role of ICG in the setting of multimodal imaging
When evaluating a nonpigmented choroidal lesion, ICG findings should not be interpreted in isolation, but rather in consort with the findings of other noninvasive imaging modalities, including ultrasonography with A- and B-scans and EDI-OCT. An experienced clinician may not find angiographic studies essential to confirm the diagnosis of CCH in classic cases; however, relying on ophthalmoscopic appearance alone is fraught with pitfalls and may lead to misdiagnosis of malignant lesions as CCH, resulting in a delay of appropriate treatment [26].
The differential diagnosis of red-orange fundus lesions includes both benign and malignant tumors. Choroidal metastasis, particularly those arising from bronchial carcinoid tumor, thyroid cancer or renal cell carcinoma, can mimic the red-orange appearance of CCH. Enhanced depth imaging-OCT may be particularly illuminating in these cases, as choroidal metastasis often show a characteristic “lumpy bumpy” topography with compression of the overlying choriocapillaris [27], and on ICG a subtle, diffuse homogenous isofluorescence with late hypofluorescence is often seen [23]. Uveal lymphoma may also mimic CCH; however, hypofluorescence throughout ICG [28] and a “flat, rippled, or undulating (seasick)” topography on EDI-OCT [29] help to distinguish this entity.
As technology continues to advance in the field of ophthalmic imaging, novel modalities, such as OCT-angiography (OCT-A) may supplant traditional angiography in certain chorioretinal conditions. However, the current utility of OCT-A in CCH is limited given the inability of this technology to capture vascular anatomy deep to the superficial choriocapillaris. Given that the choriocapillaris is uninvolved in CCH [30] ICG remains the only angiographic modality by which to assess the affected Haller’s and Sattler’s layers in this entity.
The role of ICG in guiding treatment of chorioretinal disorders including CCH
In addition to aiding in the accurate diagnosis of chorioretinal conditions, ICG has be used to guide laser photocoagulation of occult choroidal neovascularization [31] and photodynamic therapy for central serous chorioretinopathy [18]. Although several treatment modalities for CCH exist, including argon laser photocoagulation, transpupillary thermotherapy, plaque brachytherapy, and lens sparing external beam radiotherapy, recent reports have shown excellent visual outcomes following treatment with PDT [32, 33]. Indocyanine green guided PDT allows for more precise spot size selection and placement, thus optimizing treatment of the CCH while minimizing unnecessary damage to surrounding structures.
Limitations of this report relate primarily to the duration of ICG angiography studies. The mean latest frame for all 35 patients included occurred at 13 min 13 s, which is a significantly shorter duration than previous reports that recorded the latest frame at 35 min [11]. While the difference in angiography times between groups was not statistically significant, only three patients in this study had late frames >30 min and all three were in the SLO group. As a result, we have emphasized the early and mid-frame findings of CCH in this report, but noteworthy is that all cases on either imaging platform showed a decrease in fluorescence by the latest frame taken.
This report has updated the ICG imaging characteristics of CCH using widely available platforms in modern ophthalmic practice that utilize an SLO imaging system. In summary, ICG imaging of CCH on SLO platforms shows more prominent intrinsic vessels and vascular loops that remain visible throughout the entire angiogram, a granular rather than feathery diffuse hyperfluorescence in mid frames and more conspicuous “hot spots” on mid-late frames compared with DCS. Addition of these early and mid-frame characteristic features to the clinical assessment of suspected CCH may negate the need for late frames >30 min without compromising diagnostic accuracy.
Summary
What was known before
Circumscribed choroidal haemangioma (CCH) is a benign vascular hamartoma with a red-orange appearance most commonly involving the superotemporal quadrant of the macula and often presenting in the 5th decade of life.
Indocyanine green (ICG) angiography is often used, in consort with other imaging modalities including ultrasonography and enhanced depth imaging optical coherence tomography, to reach the diagnosis.
Previously reported ICG findings in CCH captured on digital camera systems (DCS; Topcon) include early hyperfluorescence, late washout, visualization of intrinsic vessels, a later hyperfluorescent rim, and late hot spots.
What this study adds
Patterns on ICG captured with newer scanning laser ophthalmoscopy platforms (SLO; Optos California and Heidelberg Spectralis) differ from that observed with DCS in several ways. The most striking difference between the imaging modalities was the visualization of intrinsic vessels and vascular loops throughout the entire duration of the ICG.
The color photograph of CCH obtained on SLO often has a green-gray hue which can be misleading; however, the blend function can be used to obtain a red separation image which more clearly highlights the true extent of the lesion.
The pattern at maximum hyperfluorescence on SLO tends to have a granular appearance and “hot spots” are more conspicuous on mid-late frames compared with DCS. Improved visualization of these characteristic features on mid-late frames may negate the need for late frames > 30 min without compromising diagnostic accuracy.
Acknowledgements
All authors contributed to the body of work presented herein. The authors would like to acknowledge the Ophthalmic Imaging Department at Moorfields Eye Hospital for their role in image acquisition. The research was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Shields CL, Honavar SG, Shields JA, Cater J, Demirci H. Circumscribed choroidal hemangioma: clinical manifestations and factors predictive of visual outcome in 200 consecutive cases. Ophthalmology. 2001;108:2237–48. doi: 10.1016/S0161-6420(01)00812-0. [DOI] [PubMed] [Google Scholar]
- 2.Krohn J, Rishi P, Froystein T, Singh AD. Circumscribed choroidal haemangioma: clinical and topographical features. Br J Ophthalmol. 2019;103:1448–52. doi: 10.1136/bjophthalmol-2018-313388. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Singh ADDB, Pe’er J. Clinical ophthalmic oncology. Philadelphia, PA: Saunders Elsevier; 2007. [Google Scholar]
- 4.Kim RS, Jain RR, Brown DM, Bretana ME, Kegley EN, Singer MA, et al. Elevated choroidal thickness and central serous chorioretinopathy in the fellow eyes of patients with circumscribed choroidal hemangioma. Ocul Oncol Pathol. 2018;4:375–80. doi: 10.1159/000486864. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Sobol EK, Francis JH, Abramson DH, Freund KB, Spaide RF, Barbazetto I. Subfoveal choroidal thickness and vascular architecture in fellow eyes of patients with circumscribed choroidal hemangioma. Retina. 2020;40:758–64. doi: 10.1097/IAE.0000000000002438. [DOI] [PubMed] [Google Scholar]
- 6.Verbeek AM, Koutentakis P, Deutman AF. Circumscribed choroidal hemangioma diagnosed by ultrasonography. A retrospective analysis of 40 cases. Int Ophthalmol. 1995;19:185–9. doi: 10.1007/BF00133736. [DOI] [PubMed] [Google Scholar]
- 7.Rojanaporn D, Kaliki S, Ferenczy SR, Shields CL. Enhanced depth imaging optical coherence tomography of circumscribed choroidal hemangioma in 10 consecutive cases. Middle East Afr J Ophthalmol. 2015;22:192–7. doi: 10.4103/0974-9233.150629. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Shah SU, Kaliki S, Shields CL, Ferenczy SR, Harmon SA, Shields JA. Enhanced depth imaging optical coherence tomography of choroidal nevus in 104 cases. Ophthalmology. 2012;119:1066–72. doi: 10.1016/j.ophtha.2011.11.001. [DOI] [PubMed] [Google Scholar]
- 9.Shields CL, Kaliki S, Rojanaporn D, Ferenczy SR, Shields JA. Enhanced depth imaging optical coherence tomography of small choroidal melanoma: comparison with choroidal nevus. Arch Ophthalmol. 2012;130:850–6. doi: 10.1001/archophthalmol.2012.1135. [DOI] [PubMed] [Google Scholar]
- 10.Witkin AJ, Fischer DH, Shields CL, Reichstein D, Shields JA. Enhanced depth imaging spectral-domain optical coherence tomography of a subtle choroidal metastasis. Eye. 2012;26:1598–9. doi: 10.1038/eye.2012.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Arevalo JF, Shields CL, Shields JA, Hykin PG, De Potter P. Circumscribed choroidal hemangioma: characteristic features with indocyanine green videoangiography. Ophthalmology. 2000;107:344–50. doi: 10.1016/S0161-6420(99)00051-2. [DOI] [PubMed] [Google Scholar]
- 12.Hassenstein A, Meyer CH. Clinical use and research applications of Heidelberg retinal angiography and spectral-domain optical coherence tomography - a review. Clin Exp Ophthalmol. 2009;37:130–43. doi: 10.1111/j.1442-9071.2009.02017.x. [DOI] [PubMed] [Google Scholar]
- 13.Yannuzzi LA, Slakter JS, Sorenson JA, Guyer DR, Orlock DA. Digital indocyanine green videoangiography and choroidal neovascularization. Retina. 1992;12:191–223. doi: 10.1097/00006982-199212030-00003. [DOI] [PubMed] [Google Scholar]
- 14.Yannuzzi LA. Indocyanine green angiography: a perspective on use in the clinical setting. Am J Ophthalmol. 2011;151:745–51, e741. doi: 10.1016/j.ajo.2011.01.043. [DOI] [PubMed] [Google Scholar]
- 15.Yannuzzi LA, Wong DW, Sforzolini BS, Goldbaum M, Tang KC, Spaide RF, et al. Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol. 1999;117:1503–10. doi: 10.1001/archopht.117.11.1503. [DOI] [PubMed] [Google Scholar]
- 16.Rouvas AA, Papakostas TD, Ntouraki A, Douvali M, Vergados I, Ladas ID. Angiographic and OCT features of retinal angiomatous proliferation. Eye. 2010;24:1633–42. doi: 10.1038/eye.2010.134. [DOI] [PubMed] [Google Scholar]
- 17.Inoue R, Sawa M, Tsujikawa M, Gomi F. Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy. Am J Ophthalmol. 2010;149:441–6, e441–2. doi: 10.1016/j.ajo.2009.10.011. [DOI] [PubMed] [Google Scholar]
- 18.Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa D, Huang SJ, et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina. 2003;23:288–98. doi: 10.1097/00006982-200306000-00002. [DOI] [PubMed] [Google Scholar]
- 19.Bouchenaki N, Cimino L, Auer C, Tao Tran V, Herbort CP. Assessment and classification of choroidal vasculitis in posterior uveitis using indocyanine green angiography. Klin Monbl Augenheilkd. 2002;219:243–9. doi: 10.1055/s-2002-30661. [DOI] [PubMed] [Google Scholar]
- 20.Balasubramaniam SC, Pellegrini M, Staurenghi G, Pulido JS. Infrared imaging of circumscribed choroidal hemangiomas. Retina. 2017;37:1134–9. doi: 10.1097/IAE.0000000000001317. [DOI] [PubMed] [Google Scholar]
- 21.Schalenbourg A, Piguet B, Zografos L. Indocyanine green angiographic findings in choroidal hemangiomas: a study of 75 cases. Ophthalmologica. 2000;214:246–52. doi: 10.1159/000027499. [DOI] [PubMed] [Google Scholar]
- 22.Shields JA, Mashayekhi A, Ra S, Shields CL. Pseudomelanomas of the posterior uveal tract: the 2006 Taylor R. Smith Lecture. Retina. 2005;25:767–71. doi: 10.1097/00006982-200509000-00013. [DOI] [PubMed] [Google Scholar]
- 23.Shields CL, Shields JA, De Potter P. Patterns of indocyanine green videoangiography of choroidal tumours. Br J Ophthalmol. 1995;79:237–45. doi: 10.1136/bjo.79.3.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Shiraki K, Moriwaki M, Yanagihara N, Kohno T, Miki T. Indocyanine green angiograms of choroidal nevi. comparison between confocal and nonconfocal scanning laser ophthalmoscope and fundus video camera. Jpn J Ophthalmol. 2001;45:368–74. doi: 10.1016/S0021-5155(01)00362-8. [DOI] [PubMed] [Google Scholar]
- 25.Tan CS, Ting DS, Lim LW. Multicolor fundus imaging of polypoidal choroidal vasculopathy. Ophthalmol Retin. 2019;3:400–9. doi: 10.1016/j.oret.2019.01.009. [DOI] [PubMed] [Google Scholar]
- 26.Campagnoli TR, Medina CA, Singh AD. Choroidal melanoma initially treated as hemangioma: diagnostic and therapeutic considerations. Retin Cases Brief Rep. 2016;10:175–82. doi: 10.1097/ICB.0000000000000220. [DOI] [PubMed] [Google Scholar]
- 27.Al-Dahmash SA, Shields CL, Kaliki S, Johnson T, Shields JA. Enhanced depth imaging optical coherence tomography of choroidal metastasis in 14 eyes. Retina. 2014;34:1588–93. doi: 10.1097/IAE.0000000000000131. [DOI] [PubMed] [Google Scholar]
- 28.Aronow ME, Portell CA, Sweetenham JW, Singh AD. Uveal lymphoma: clinical features, diagnostic studies, treatment selection, and outcomes. Ophthalmology. 2014;121:334–41. doi: 10.1016/j.ophtha.2013.09.004. [DOI] [PubMed] [Google Scholar]
- 29.Shields CL, Manalac J, Das C, Saktanasate J, Shields JA. Review of spectral domain enhanced depth imaging optical coherence tomography of tumors of the choroid. Indian J Ophthalmol. 2015;63:117–21. doi: 10.4103/0301-4738.154377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Witschel H, Font RL. Hemangioma of the choroid. A clinicopathologic study of 71 cases and a review of the literature. Surv Ophthalmol. 1976;20:415–31. doi: 10.1016/0039-6257(76)90067-9. [DOI] [PubMed] [Google Scholar]
- 31.Slakter JS, Yannuzzi LA, Sorenson JA, Guyer DR, Ho AC, Orlock DA. A pilot study of indocyanine green videoangiography-guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration. Arch Ophthalmol. 1994;112:465–72. doi: 10.1001/archopht.1994.01090160041020. [DOI] [PubMed] [Google Scholar]
- 32.Shields CL, Dalvin LA, Lim LS, Chang M, Udyaver S, Mazloumi M, et al. Circumscribed choroidal hemangioma: visual outcome in the pre-photodynamic therapy era versus photodynamic therapy era in 458 cases. Ophthalmol Retina. 2019;4:100–10. doi: 10.1016/j.oret.2019.08.004. [DOI] [PubMed] [Google Scholar]
- 33.Papastefanou VP, Plowman PN, Reich E, Pavlidou E, Restori M, Hungerford JL, et al. Analysis of long-term outcomes of radiotherapy and verteporfin photodynamic therapy for circumscribed choroidal hemangioma. Ophthalmol Retin. 2018;2:842–57. doi: 10.1016/j.oret.2017.12.002. [DOI] [PubMed] [Google Scholar]




